1-10 of 10
Yukihiko Kimura, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All- Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study

Takaaki Ono, MD, PhD, Akihiro Takeshita, MD, PhD, Katsuji Shinagawa, MD, PhD, Yuji Kishimoto, MD, PhD, Hitoshi Kiyoi, MD, PhD, Masaya Okada, MD, PhD, Takahiro Yamauchi, MD, PhD, Nobuhiko Emi, MD, PhD, Hiroyuki Fujita, MD, Mitsuhiro Matsuda, MD, PhD, Fumihiko Monma, MD, PhD, Shigeki Ohtake, MD, PhD, Chiaki Nakaseko, M.D., Ph.D., Masatomo Takahashi, MD, PhD, Yukihiko Kimura, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Norio Asou, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3950.
https://doi.org/10.1182/blood.V122.21.3950.3950
Published: 2013
Journal Articles

Clinical Features and Prognostic Impact of CD56 Expression in Acute Promyelocytic Leukemia: Long Term Follow up Data From the Japan Adult Leukemia Study Group(JALSG) APL97,

Takaaki Ono, MD, PhD, Akihiro Takeshita, MD, PhD, Yuji Kishimoto, MD, PhD, Hitoshi Kiyoi, MD, PhD, Masaya Okada, MD, PhD, Takahiro Yamauchi, MD, PhD, Motohiro Tsuzuki, MD, PhD, Kentaro Horikawa, MD, PhD, Mitsuhiro Matsuda, MD, PhD, Katsuji Shinagawa, Fumihiko Monma, MD, PhD, Shigeki Ohtake, MD, PhD, Chiaki Nakaseko, MD, PhD, Masatomo Takahashi, MD, Fumiharu Yagasaki, MD, PhD, Yukihiko Kimura, MD, PhD, Hiroyuki Fujita, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Norio Asou, MD, PhD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3608.
https://doi.org/10.1182/blood.V118.21.3608.3608
Published: 2011
Journal Articles

Clinical Features and Outcomes of Elderly Patients with Acute Promyelocytic Leukemia (APL) - the Japan Adult Leukemia Study Group APL97 Study.

Takaaki Ono, MD, Akihiro Takeshita, MD, PhD, Yuji Kishimoto, MD, PhD, Hitoshi Kiyoi, MD, PhD, Masaya Okada, MD, PhD, Yasukazu Kawai, MD, PhD, Motohiro Tsuzuki, MD, PhD, Kentaro Horikawa, MD, PhD, Mitsuhiro Matsuda, MD, PhD, Katsuji Shinagawa, MD, PhD, Fumihiko Monma, MD, PhD, Shigeki Ohtake, MD, PhD, Chiaki Nakaseko, MD, PhD, Masatomo Takahashi, MD, Fumiharu Yagasaki, MD, PhD, Yukihiko Kimura, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Norio Asou, MD, PhD, Tomoki Naoe, MD, PhD, Ryuzo Ohno, MD
Journal: Blood
Blood (2010) 116 (21): 1077.
https://doi.org/10.1182/blood.V116.21.1077.1077
Published: 2010
Journal Articles

A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia: JALSG GML200 Study

Atsushi Wakita, MD, Shigeki Ohtake, MD, Satoru Takada, MD, Fumiharu Yagasaki, MD, Hirokazu Komatsu, MD, Yasushi Miyazaki, MD, Koumei Kubo, MD, Yukihiko Kimura, MD, Akihiro Takeshita, MD, Yoko Adachi, MD, Hitoshi Kiyoi, MD, Takuhiro Yamaguchi, PhD, Minoru Yoshida, MD, Kazunori Ohnishi, MD, Shuichi Miyawaki, MD, Tomoki Naoe, MD, Ryuzo Ueda, MD, Ryuzo Ohno, MD
Journal: Blood
Blood (2008) 112 (11): 2961.
https://doi.org/10.1182/blood.V112.11.2961.2961
Published: 2008
Journal Articles

Updated Results of JALSG AML201 Study Comparing Intensified Daunorubicin with Idarubicin in Patients with De Novo Acute Myeloid Leukemia: Effect of Hematopoietic Stem Cell Transplantation.

Shigeki Ohtake, MD, Shuichi Miyawaki, MD, Hiroyuki Fujita, MD, Hitoshi Kiyoi, MD, Katsuji Shinagawa, MD, Noriko Usui, MD, Kohichi Miyamura, MD, Miki Nishimura, MD, Yasushi Miyazaki, MD, Kazuhiro Nishii, MD, Tadashi Nagai, MD, Takahisa Yamane, MD, Masafumi Taniwaki, MD, Masatomo Takahashi, MD, Fumiharu Yagasaki, MD, Yukihiko Kimura, MD, Norio Asou, MD, Sumihisa Honda, Ph.D., Kazunori Ohnishi, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD
Journal: Blood
Blood (2008) 112 (11): 2171.
https://doi.org/10.1182/blood.V112.11.2171.2171
Published: 2008
Journal Articles

Randomized Clinical Trial of Induction Therapy Comparing Intensified Daunorubicin with Idarubicin in Patients with Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study).

Shigeki Ohtake, MD, Shuichi Miyawaki, MD, Hiroyuki Fujita, MD, Hitoshi Kiyoi, MD, Katsuji Shinagawa, MD, Noriko Usui, MD, Koichi Miyamura, MD, Miki Nishimura, MD, Yasushi Miyazaki, MD, Kazuhiro Nishii, MD, Tadashi Nagai, MD, Takahisa Yamane, MD, Masafumi Taniwaki, MD, Masatomo Takahashi, MD, Fumiharu Yagasaki, MD, Yukihiko Kimura, MD, Norio Asou, MD, Sumihisa Honda, PhD, Kazunori Ohnishi, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD
Journal: Blood
Blood (2006) 108 (11): 2000.
https://doi.org/10.1182/blood.V108.11.2000.2000
Published: 2006
Journal Articles

Postremission Therapy in Adult Acute Myeloid Leukemia (AML): A Randomized Comparison between High Dose Ara-C Therapy and Conventional Consolidation Therapy (JALSG AML 201 Study).

Shuichi Miyawaki, MD, Shigeki Ohtake, MD, Shin Fujisawa, MD, Hitoshi Kiyoi, MD, Katsuji Shinagawa, MD, Noriko Usui, MD, Koichi Miyamura, MD, Miki Nishimura, MD, Yasushi Miyazaki, MD, Kazuhiro Nishii, MD, Tadashi Nagai, MD, Takahisa Yamane, MD, Masafumi Taniwaki, MD, Masatomo Takahashi, MD, Fumiharu Yagasaki, PhD, Yukihiko Kimura, MD, Norio Asou, MD, Sumihisa Honda, PhD, Kazunori Ohnishi, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD
Journal: Blood
Blood (2006) 108 (11): 2005.
https://doi.org/10.1182/blood.V108.11.2005.2005
Published: 2006
Journal Articles

A Randomized Study with or without Intensified Maintenance Chemotherapy in Patients with Acute Promyelocytic Leukemia Who Had Become Negative for PML-RARα Transcript after Consolidation Therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 Study.

Norio Asou, MD, Yuji Kishimoto, MD, Hitoshi Kiyoi, MD, Masaya Okada, MD, Yasukazu Kawai, MD, Motohiro Tsuzuki, MD, Kentaro Horikawa, MD, Mitsuhiro Matsuda, MD, Katsuji Shinagawa, MD, Tohru Kobayashi, MD, Shigeki Ohtake, MD, Miki Nishimura, MD, Masatomo Takahashi, MD, Fumiharu Yagasaki, MD, Akihiro Takeshita, MD, Yukihiko Kimura, MD, Masako Iwanaga, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD
Journal: Blood
Blood (2006) 108 (11): 2009.
https://doi.org/10.1182/blood.V108.11.2009.2009
Published: 2006
Journal Articles

Myelodysplastic Syndromes with Myelofibrosis May Be a Target for the JAK2 V617F Tyrosine Kinase Mutation.

Kazuma Ohyashiki, MD, Yasuo Aota, MD, Akihiko Gotoh, MD, Keisuke Miyazawa, MD, Yukihiko Kimura, MD, Junko H. Ohyashiki, MD
Journal: Blood
Blood (2005) 106 (11): 4895.
https://doi.org/10.1182/blood.V106.11.4895.4895
Published: 2005
Journal Articles

Anti-Interleukin 6 Receptor Monoclonal Antibody Therapy Reduced Serum Interleukin 4 and IgE Production in Castleman’s Disease.

Hideko Nakahara, MD, Naoko Hoshino-Yoshio, MD, Yuzuru Kanakura, MD, Yasuo Ikeda, MD, Minoru Nakamura, MD, Shuji Nakano, MD, Toshio Tanaka, MD, Takeshi Sasaki, MD, Kiyoshi Nishioka, MD, Masamichi Hara, MD, Hirokuni Taguchi, MD, Yukihiko Kimura, MD, Yoshiro Kato, MD, Hideki Asaoku, MD, Fumio Kodama, MD, Katsuyuki Aozasa, MD, Takeshi Johkoh, MD, Tadamitsu Kishimoto, MD, Norihiro Nishimoto, MD, for the Japanese, MRA Study Group on MCD
Journal: Blood
Blood (2005) 106 (11): 1510.
https://doi.org/10.1182/blood.V106.11.1510.1510
Published: 2005